23andMe Holding Co. (ME) vs Teladoc Health, Inc. (TDOC)

A side-by-side comparison of 23andMe Holding Co. and Teladoc Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnME vs TDOC

growth of $100 · dividends reinvested · last 5y
ME -99.7%TDOC -97.2%TDOC compounded faster
Log scale — wide-divergence pair
01101001kStart $100202120222023202420252026$0$3
ME TDOC

ME vs TDOC: by the numbers

  • TDOC is the larger company ($1.24B vs $15M market cap).
  • Both run net losses; TDOC's is the smaller (-7.13% vs -134.54% net margin).
  • TDOC grew revenue faster over the past five years (8.85% vs -9.07% CAGR).

Metrics side by side

Valuation

MetricMETDOC
P/S ratio0.100.48
P/B ratio0.510.92
EV / EBITDAN/A14.32
FCF yieldN/A18.69%

Profitability

MetricMETDOC
Gross margin53.33%73.53%
Operating margin-126.72%-6.98%
Net margin-134.54%-7.13%
ROE-721.75%-13.54%
ROIC-553.10%-8.26%

Growth (annualized)

MetricMETDOC
Revenue CAGR (5Y)-9.07%8.85%
FCF CAGR (5Y)N/A25.56%
Total return CAGR (5Y)-68.93%-46.28%

Frequently asked

Which has grown faster, ME or TDOC?
Over the past five years, TDOC grew revenue faster — ME at a -9.07% CAGR versus TDOC at 8.85%.
How have ME and TDOC total returns compared?
Over the past 5 years, ME delivered -68.93% and TDOC delivered -8.72% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 6, 2026.